DS
GNTX icon

David Shaw’s Gentex GNTX Stock Holding History

David Shaw’s Portfolio GNTX Stock Details GNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-40,000
Closed -$631K – 4325
2014
Q1 		$631K Hold
40,000
– – ﹤0.01% 3407
2013
Q4 		$660K Buy
+40,000
New +$586K ﹤0.01% 3520

Other funds holding GNTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's GNTX Position: Q2 2026 in Review

David Shaw sold out of Gentex (GNTX) in Q2 2026, closing a stake of 15,843 shares — an estimated $346K sold.

David Shaw first reported a position in GNTX in Q2 2013 and held it in 48 quarters. The position peaked at $91.2M in Q3 2021. 527 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • David Shaw reported no remaining Gentex position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 15,843 Gentex shares in Q2 2026, an estimated $346K.
  • David Shaw first reported a position in Gentex in Q2 2013 and held it in 48 quarters.
  • David Shaw's Gentex position peaked at $91.2M in Q3 2021.
  • 527 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.